Principal Financial Group Inc Myriad Genetics Inc Transaction History
Principal Financial Group Inc
- $176 Billion
- Q2 2025
A detailed history of Principal Financial Group Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 456,867 shares of MYGN stock, worth $2.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
456,867
Previous 453,251
0.8%
Holding current value
$2.75 Million
Previous $4.02 Million
39.68%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding MYGN
# of Institutions
233Shares Held
94.1MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$29 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$27.7 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...